Equities

Avalon Globocare Corp

ALBT:NAQ

Avalon Globocare Corp

Actions
Real EstateReal Estate Investment and Services
  • Price (USD)0.295
  • Today's Change-0.025 / -7.81%
  • Shares traded4.00
  • 1 Year change-84.47%
  • Beta0.3017
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.

  • Revenue in USD (TTM)1.26m
  • Net income in USD-16.71m
  • Incorporated2014
  • Employees5.00
  • Location
    Avalon Globocare Corp4400 ROUTE 9, SUITE 3100FREEHOLD 07728United StatesUSA
  • Phone+1 (732) 780-4400
  • Fax+1 (732) 780-5600
  • Websitehttp://www.avalon-globocare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cano Health Inc2.96bn-981.97m1.68m2.70k------0.0006-288.02-288.02894.93-163.911.98--19.941,094,546.00-101.44---125.72-------51.32-----6.02----14.56---186.78------
Mitesco Inc0.00-10.91m1.78m3.00---------1.91-1.940.00-2.600.00----0.00-10,172.81-246.54-----------29,214.62---0.1207---------59.12------
Modern Mobility Aids Inc0.00-1.59m1.80m-----------0.0177-0.01770.00-0.0040.00-------4,668.68---------------------------371.94------
QHSLab Inc1.41m-468.37k1.84m4.00------1.31-0.0499-0.04990.1496-0.03860.774415.9823.66352,250.00-25.74-51.17---197.3156.32---33.24-65.100.0637-1.041.27--13.34--52.98------
CompuMed Inc1.78m-151.00k2.37m8.00--18.21--1.33-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
IMD Companies Inc439.50k-330.55k2.46m3.00------5.61-0.0053-0.00530.0049-0.00210.430331.325.58146,500.00-32.36-41.61-43.47-58.1633.5249.68-75.21-89.491.05--1.48--26.65---47.11------
IMAC Holdings Inc0.00-5.63m3.27m2.00---------5.04-5.460.00-1.080.00--0.000.00-166.65-48.88-1,050.71-70.25-------97.63---14.97--------45.27------
Avalon Globocare Corp1.26m-16.71m3.28m5.00------2.61-1.54-1.540.1180.66990.0623--9.73251,136.00-82.84-100.94-111.41-134.5118.9724.44-1,330.52-1,011.06---0.73640.5319--4.45-4.28-40.03---51.83--
Assure Holdings Corp255.00k-21.45m3.80m95.00------14.89-3.80-4.600.055-2.280.0161--0.02722,684.21-135.04-35.15-937.78-46.37-860.3937.14-8,410.59-116.06---5.92-----45.86-55.626.19------
OpGen Inc3.07m-26.16m3.86m100.00--1.14--1.26-65.10-65.105.502.670.12022.915.6430,702.30-102.41-79.05-196.63-110.126.6222.60-852.12-706.290.1809-7.530.7746---39.45-4.0811.17--16.36--
Rennova Health Inc20.30m2.38m4.31m85.0010.00--1.570.2120.000010.000010.00008-0.00071.0127.777.93238,855.3011.79-116.33----63.107.2211.66-159.890.11471.86----304.3633.3834.70---52.27--
Data as of May 31 2024. Currency figures normalised to Avalon Globocare Corp's reporting currency: US Dollar USD

Institutional shareholders

0.90%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202434.50k0.31%
Geode Capital Management LLCas of 31 Mar 202420.42k0.18%
SSgA Funds Management, Inc.as of 31 Mar 202419.12k0.17%
Millennium Management LLCas of 31 Mar 202412.76k0.12%
Tower Research Capital LLCas of 31 Mar 20248.19k0.07%
UBS Securities LLCas of 31 Mar 20244.50k0.04%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024200.000.00%
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 202428.000.00%
Sound Income Strategies LLCas of 31 Mar 202410.000.00%
RBC Dominion Securities, Inc.as of 31 Mar 20244.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.